Company Filing History:
Years Active: 2021
Title: Yunzhan Li: Innovator in Pharmaceutical Compounds
Introduction
Yunzhan Li is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienopyrimidine compounds. His research focuses on developing compounds that have selective inhibitory activity against ALK and c-Met, which are crucial in treating various diseases.
Latest Patents
Yunzhan Li holds a patent for a thienopyrimidine compound, which includes a preparation method, pharmaceutical composition, and its applications. This invention is particularly relevant for its potential use in preventing or treating diseases associated with anaplastic lymphoma kinase, angiogenesis, and cancer metastasis. The patent emphasizes the importance of these compounds in the manufacture of medicaments aimed at tumor growth and metastasis.
Career Highlights
Throughout his career, Yunzhan Li has worked with prominent organizations such as Hongyun Biotech Co., Ltd. and Xiamen University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Yunzhan Li has collaborated with esteemed colleagues, including Xianming Deng and Baoding Zhang. These partnerships have fostered a productive environment for innovation and research in the pharmaceutical sector.
Conclusion
Yunzhan Li's work in developing thienopyrimidine compounds showcases his dedication to advancing medical science. His contributions are vital for the ongoing fight against cancer and related diseases.